Biotech · Private company
Vyne Therapeutics Inc.
Track this companyFree. Adds Vyne Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials200 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline22
- 5 mg Serlopitant TabletsPhase 3 · PruritusClinicalTrials.gov · fetched Nov 12, 2026
- 5mg Serlopitant TabletsPhase 3 · PruritusClinicalTrials.gov · fetched Nov 12, 2026
- FMX-101, 4% minocycline foamPhase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- FMX101Phase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- FMX103 1.5%Phase 3 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- FMX103 minocycline foam 1.5%Phase 3 · Facial Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle foamPhase 3 · Facial Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle FoamPhase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- 0.3% Adapalene FoamPhase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- 3% Minocycline FoamPhase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- 5 mg Serlopitant TabletsPhase 2 · Refractory Chronic CoughClinicalTrials.gov · fetched Nov 12, 2026
- FCD105Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- FMX114Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- SerlopitantPhase 2 · PruritusClinicalTrials.gov · fetched Nov 12, 2026
- Serlopitant High DosePhase 2 · PruritusClinicalTrials.gov · fetched Nov 12, 2026
- Serlopitant Low DosePhase 2 · PruritusClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle GelPhase 2 · Non-segmental VitiligoClinicalTrials.gov · fetched Nov 12, 2026
- VPD-737Phase 2 · Chronic PruritusClinicalTrials.gov · fetched Nov 12, 2026
- VYN201 GelPhase 2 · Non-segmental VitiligoClinicalTrials.gov · fetched Nov 12, 2026
- FMX101 vehiclePhase 1 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Hydro-alcohol solutionPhase 1 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials20
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.PHASE2 · TERMINATED · started Jun 4, 2024ClinicalTrials.gov NCT06493578 · fetched Nov 12, 2026
- Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic DermatitisPHASE1_PHASE2 · COMPLETED · started Oct 13, 2021ClinicalTrials.gov NCT04927572 · fetched Nov 12, 2026
- A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.PHASE2 · COMPLETED · started Sep 18, 2019ClinicalTrials.gov NCT04104685 · fetched Nov 12, 2026
- A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis BullosaPHASE2 · COMPLETED · started Apr 18, 2019ClinicalTrials.gov NCT03836001 · fetched Nov 12, 2026
- Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown OriginPHASE2 · COMPLETED · started Jan 22, 2019ClinicalTrials.gov NCT03841331 · fetched Nov 12, 2026
- A Study Comparing Two Topicals in the Treatment of Acne VulgarisPHASE1 · COMPLETED · started Nov 20, 2018ClinicalTrials.gov NCT03743038 · fetched Nov 12, 2026
- Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo NodularisPHASE3 · COMPLETED · started May 2, 2018ClinicalTrials.gov NCT03546816 · fetched Nov 12, 2026
- Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)PHASE3 · TERMINATED · started Mar 15, 2018ClinicalTrials.gov NCT03540160 · fetched Nov 12, 2026
- Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque PsoriasisPHASE2 · COMPLETED · started Nov 1, 2017ClinicalTrials.gov NCT03343639 · fetched Nov 12, 2026
- Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic CoughPHASE2 · COMPLETED · started Oct 3, 2017ClinicalTrials.gov NCT03282591 · fetched Nov 12, 2026
- A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular RosaceaPHASE3 · COMPLETED · started Sep 5, 2017ClinicalTrials.gov NCT03276936 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne VulgarisPHASE3 · COMPLETED · started Jul 17, 2017ClinicalTrials.gov NCT03271021 · fetched Nov 12, 2026
- A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular RosaceaPHASE3 · COMPLETED · started Jun 2, 2017ClinicalTrials.gov NCT03142451 · fetched Nov 12, 2026
- A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular RosaceaPHASE3 · COMPLETED · started Jun 1, 2017ClinicalTrials.gov NCT04608500 · fetched Nov 12, 2026
- Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn InjuryPHASE2 · TERMINATED · started Nov 1, 2016ClinicalTrials.gov NCT02975271 · fetched Nov 12, 2026
- Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic DermatitisPHASE2 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02975206 · fetched Nov 12, 2026
- A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe AcnePHASE3 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02815280 · fetched Nov 12, 2026
- A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe AcnePHASE3 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02815267 · fetched Nov 12, 2026
- A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of ScabiesPHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02094716 · fetched Nov 12, 2026
- VPD-737 for Treatment of Chronic PruritusPHASE2 · COMPLETED · started Oct 15, 2013ClinicalTrials.gov NCT01951274 · fetched Nov 12, 2026